Fabio Badilini

Last updated
Fabio Badilini
Born
Fabio Francesco Badilini

(1964-10-22) 22 October 1964 (age 58)
Nationality Italian

Fabio Badilini (born 22 October 1964 in Montichiari, Brescia) is an Italian scientist and business man. He has made major contributions to noninvasive electrocardiography not only through his individual contributions, but also through his truly remarkable ability to foster collaborations across scientific disciplines, academic institutions, governmental agencies, device manufacturers and industries around the world.

Contents

Early life and education

Badilini received a master' s degree in biomedical engineering at the Politecnico University of Milan, Italy, in 1989 under Sergio Cerutti. [1] There he focused on aspects of heart rate variability that led to the development of computer applications that are today widely employed in the field of central nervous system analysis. He received his Ph.D. in electrical engineering from the University of Rochester [2] [3] in 1994 under Arthur J. Moss. His thesis was on beat-to-beat ST segment displacement assessment in Holter recordings. His major innovations related to ST segment variability analyses have given new impetus to improved quantitative analysis of noninvasive electrocardiographic recordings. His techniques and approaches are widely used. While working as a post-doctoral fellow with Philippe Coumel [4] at Lariboisiere Hospital [5] in Paris from 1994 to 1998, Badilini was instrumental in the development of the Holter Bin Method [6] [7] for assessing the effect of heart rate upon the QT interval that has been used in New Drug Applications to the FDA.

Career

1990s

In 1998, he led the working team that defined the ISHNE [8] ECG format [9] from ambulatory ECG recordings. Notably, he was the lead technical contributor in the creation of data standards for digital ECGs submitted to the FDA ECG Warehouse [10] [11] used for the safety evaluation of new drugs. Badilini also developed the first ECG computer application used by the FDA to review digital ECG files on the ECG recordings electronically submitted with the new standard. Nearly every provider of ECG safety data in the drug approval process worldwide uses his tools. In addition to these contributions on standard ECG signal processing, he has developed tools to extract optimal ECG waveforms from 12-lead Holter data based upon recording artifact and heart rate stability for QT measurement.

2000s

Since 1998, he has worked in the pharmaceutical industry arena, and he is the founder and executive vice president of AMPS-LLC, [12] NY, a company tailoring software-oriented solutions involving analysis of biomedical signals. He maintains a series of worldwide academic collaborations with leaders in many aspects of cardiovascular signals processing.

Honors and awards

Published work

Notes

  1. "Sergio Cerutti Archived 2008-08-04 at the Wayback Machine " - Professor in Biomedical Signal and Data Processing at the Department of Biomedical Engineering of the Politecnico di Milano, Italy.
  2. "University of Rochester"
  3. "University of Rochester Medical Center - Heart Research Follow Up (HRFP)"
  4. "Philippe Coumel Archived 2009-01-05 at the Wayback Machine - Biography"
  5. "Lariboisiere Hospital"
  6. Badilini, Fabio; Maison-Blanche, P; Childers, R; Coumel, P (1999). "QT interval analysis on ambulatory electrocardiogram recordings: a selective beat averaging approach". Med Biol Eng Comput. 37 (1): 71–79. doi:10.1007/BF02513269. PMID   10396845.
  7. Extramiana, Fabrice; F. Badilini (2007). "Contrasting Time and Rate based approaches for the assessment of drug-induced QT changes". J Clin Pharmacol. 47 (9): 1129–1137. doi:10.1177/0091270007302953. PMID   17656619.
  8. "ISHNE", - The International Society for Holter and Noninvasive Electrocardiology
  9. Badilini, Fabio (1998). "The ISHNE Holter Standard Output File Format". Annals of Noninvasive Electrocardiology. 3 (3): 263–266. doi: 10.1111/j.1542-474x.1998.tb00353.x .
  10. "ECG Warehouse"
  11. "Providing Digital Electrocardiogram (ECG) Data" to the U.S. Food and Drug Administration (FDA)
  12. "AMPS llc", - Analyzing Medical Parameters for Solutions - NY
  13. "FDA Commissioner Special Citation" received on 2003-10-02
  14. "Mortara News Releases" referring to FDA Commissioner Special Citation
  15. "eRT press release Archived 2011-07-10 at the Wayback Machine " referring to FDA Commissioner Special Citation
  16. "Honorary Fellowship Award – 2009 Archived 2009-05-10 at the Wayback Machine ", American College of Cardiology. Received on 2009-03-30.

Related Research Articles

<span class="mw-page-title-main">Electrocardiography</span> Examination of the hearts electrical activity

Electrocardiography is the process of producing an electrocardiogram, a recording of the heart's electrical activity. It is an electrogram of the heart which is a graph of voltage versus time of the electrical activity of the heart using electrodes placed on the skin. These electrodes detect the small electrical changes that are a consequence of cardiac muscle depolarization followed by repolarization during each cardiac cycle (heartbeat). Changes in the normal ECG pattern occur in numerous cardiac abnormalities, including cardiac rhythm disturbances, inadequate coronary artery blood flow, and electrolyte disturbances.

<span class="mw-page-title-main">Ventricular fibrillation</span> Rapid quivering of the ventricles of the heart

Ventricular fibrillation is an abnormal heart rhythm in which the ventricles of the heart quiver. It is due to disorganized electrical activity. Ventricular fibrillation results in cardiac arrest with loss of consciousness and no pulse. This is followed by sudden cardiac death in the absence of treatment. Ventricular fibrillation is initially found in about 10% of people with cardiac arrest.

<span class="mw-page-title-main">Long QT syndrome</span> Medical condition

Long QT syndrome (LQTS) is a condition affecting repolarization (relaxing) of the heart after a heartbeat, giving rise to an abnormally lengthy QT interval. It results in an increased risk of an irregular heartbeat which can result in fainting, drowning, seizures, or sudden death. These episodes can be triggered by exercise or stress. Some rare forms of LQTS are associated with other symptoms and signs including deafness and periods of muscle weakness.

<span class="mw-page-title-main">Cardiac conduction system</span> Aspect of heart function

The cardiac conduction system(CCS) transmits the signals generated by the sinoatrial node – the heart's pacemaker, to cause the heart muscle to contract, and pump blood through the body's circulatory system. The pacemaking signal travels through the right atrium to the atrioventricular node, along the bundle of His, and through the bundle branches to Purkinje fibers in the walls of the ventricles. The Purkinje fibers transmit the signals more rapidly to stimulate contraction of the ventricles.

<span class="mw-page-title-main">Torsades de pointes</span> Type of abnormal heart rhythm

Torsades de pointes, torsade de pointes or torsades des pointes (TdP) is a specific type of abnormal heart rhythm that can lead to sudden cardiac death. It is a polymorphic ventricular tachycardia that exhibits distinct characteristics on the electrocardiogram (ECG). It was described by French physician François Dessertenne in 1966. Prolongation of the QT interval can increase a person's risk of developing this abnormal heart rhythm, occurring in between 1% and 10% of patients who receive QT-prolonging antiarrhythmic drugs.

<span class="mw-page-title-main">QT interval</span> Measurement made on an electrocardiogram

The QT interval is a measurement made on an electrocardiogram used to assess some of the electrical properties of the heart. It is calculated as the time from the start of the Q wave to the end of the T wave, and approximates to the time taken from when the cardiac ventricles start to contract to when they finish relaxing. An abnormally long or abnormally short QT interval is associated with an increased risk of developing abnormal heart rhythms and sudden cardiac death. Abnormalities in the QT interval can be caused by genetic conditions such as long QT syndrome, by certain medications such as sotalol or pitolisant, by disturbances in the concentrations of certain salts within the blood such as hypokalaemia, or by hormonal imbalances such as hypothyroidism.

<span class="mw-page-title-main">T wave</span> Repolarization of the ventricles in a human heart

In electrocardiography, the T wave represents the repolarization of the ventricles. The interval from the beginning of the QRS complex to the apex of the T wave is referred to as the absolute refractory period. The last half of the T wave is referred to as the relative refractory period or vulnerable period. The T wave contains more information than the QT interval. The T wave can be described by its symmetry, skewness, slope of ascending and descending limbs, amplitude and subintervals like the Tpeak–Tend interval.

Premature atrial contraction (PAC), also known as atrial premature complexes (APC) or atrial premature beats (APB), are a common cardiac dysrhythmia characterized by premature heartbeats originating in the atria. While the sinoatrial node typically regulates the heartbeat during normal sinus rhythm, PACs occur when another region of the atria depolarizes before the sinoatrial node and thus triggers a premature heartbeat, in contrast to escape beats, in which the normal sinoatrial node fails, leaving a non-nodal pacemaker to initiate a late beat.

<span class="mw-page-title-main">T wave alternans</span>

T wave alternans (TWA) is a periodic beat-to-beat variation in the amplitude or shape of the T wave in an electrocardiogram TWA was first described in 1908. At that time, only large variations could be detected. Those large TWAs were associated with increased susceptibility to lethal ventricular tachycardias.

<span class="mw-page-title-main">Acute pericarditis</span> Medical condition

Acute pericarditis is a type of pericarditis usually lasting less than 6 weeks. It is the most common condition affecting the pericardium.

<span class="mw-page-title-main">U wave</span>

The 'U' wave is a wave on an electrocardiogram (ECG). It comes after the T wave of ventricular repolarization and may not always be observed as a result of its small size. 'U' waves are thought to represent repolarization of the Purkinje fibers. However, the exact source of the U wave remains unclear. The most common theories for the origin are:

<span class="mw-page-title-main">Vectorcardiography</span>

Vectorcardiography (VCG) is a method of recording the magnitude and direction of the electrical forces that are generated by the heart by means of a continuous series of vectors that form curving lines around a central point.

<span class="mw-page-title-main">ST depression</span> Depression of the ST segment on an electrocardiogram

ST depression refers to a finding on an electrocardiogram, wherein the trace in the ST segment is abnormally low below the baseline.

<span class="mw-page-title-main">P wave (electrocardiography)</span> Represents atrial depolarization, which results in atrial contraction

The P wave on the ECG represents atrial depolarization, which results in atrial contraction, or atrial systole.

<span class="mw-page-title-main">Benign early repolarization</span> Medical condition

Benign early repolarization also known as early repolarization is found on ECG in about 1% of those with chest pain. It is diagnosed based on an elevated J-point / ST elevation with an end-QRS notch or end-QRS slur and where the ST segment concave up. It is believed to be a normal variant.

Sgarbossa's criteria are a set of electrocardiographic findings generally used to identify myocardial infarction in the presence of a left bundle branch block (LBBB) or a ventricular paced rhythm.

Heart rhythm disturbances have been seen among astronauts. Most of these have been related to cardiovascular disease, but it is not clear whether this was due to pre-existing conditions or effects of space flight. It is hoped that advanced screening for coronary disease has greatly mitigated this risk. Other heart rhythm problems, such as atrial fibrillation, can develop over time, necessitating periodic screening of crewmembers’ heart rhythms. Beyond these terrestrial heart risks, some concern exists that prolonged exposure to microgravity may lead to heart rhythm disturbances. Although this has not been observed to date, further surveillance is warranted.

QT prolongation is a measure of delayed ventricular repolarisation, which means the heart muscle takes longer than normal to recharge between beats. It is an electrical disturbance which can be seen on an electrocardiogram (ECG). Excessive QT prolongation can trigger tachycardias such as torsades de pointes (TdP). QT prolongation is an established side effect of antiarrhythmics, but can also be caused by a wide range of non-cardiac medicines, including antibiotics, antihistamines, opioids, and complementary medicines. On an ECG, the QT interval represents the summation of action potentials in cardiac muscle cells, which can be caused by an increase in inward current through sodium or calcium channels, or a decrease in outward current through potassium channels. By binding to and inhibiting the “rapid” delayed rectifier potassium current protein, certain drugs are able to decrease the outward flow of potassium ions and extend the length of phase 3 myocardial repolarization, resulting in QT prolongation.

<span class="mw-page-title-main">Right heart strain</span>

Right heart strain is a medical finding of right ventricular dysfunction where the heart muscle of the right ventricle (RV) is deformed. Right heart strain can be caused by pulmonary hypertension, pulmonary embolism, RV infarction, chronic lung disease, pulmonic stenosis, bronchospasm, and pneumothorax.

<span class="mw-page-title-main">QT interval variability</span>

QT interval variability (QTV) refers to the physiological phenomenon of beat-to-beat fluctuations in QT interval of electrocardiograms. Increased QTV appears to be a marker of arrhythmic and cardiovascular death; it may also play a role for noninvasive assessment of sympathetic nervous system activity.